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The current Kidney Disease Improving Global Outcomes (KDIGO) guidelines recommend the use 
of the bedside creatinine-based Chronic Kidney Disease in Children (CKiD) equation to estimate 
glomerular filtration rate (GFR) in children and the Chronic Kidney Disease Epidemiology 
Collaboration (CKD-EPI) equation in adults. However, this approach causes implausible changes 
in estimated GFR (eGFR) at the transition from pediatric to adult care. We investigated the 
performance of the KDIGO strategy and various creatinine-based eGFR equations in a cross-
sectional dataset of 5,764 subjects (age 10-30 years), using directly measured GFR (mGFR) as 
reference. We also evaluated longitudinal GFR slopes in 136 subjects who transitioned to adult 
care. Implausible changes in eGFR resulted from the large overestimation (bias= +21 mL/ 
min/1.73m2) and poor precision of the CKD-EPI equation in the 18-20 year age group, compared 
to CKiD in the 16-18 year age group (bias = -2.7 ml_/min/1.73m2), resulting in a mean change of 
23 mL/min/1.73m2 at the transition to adult care. Averaging the CKiD and CKD-EPI estimates in 
young adults only partially mitigated this issue. The Full Age Spectrum equation (with and 
without height), the Lund-Malmö Revised equation, and an age-dependent weighted average of 
CKiD and CKD-EPI resulted in much smaller changes in eGFR at the transition (change of 0.6, -
2.1, -0.9 and -1.8 mL/min/1.73m2, respectively). The longitudinal analysis revealed a significant 
difference in average GFR slope between mGFR and the KDIGO strategy (-2.2 vs. +2.9 
mL/min/1.73 m2/year), which was not observed with the other approaches. These results 
suggest that the KDIGO recommendation for GFR estimation at the pediatric-adult care 
transition should be revisited. 
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According to current KDIGO guidelines, eGFR is preferably done using the creatinine-based 
Chronic Kidney Disease in Children (CKiDScr) equation1 and the CKD-EPI equation2 in adults. 
However, this switch from the CKiDScr to the CKD-EPI equation in young adults can lead to 
sudden eGFR increases at 18 years. As an example, an 18-year-old male with a body height (Ht) 
of 180 cm and a serum creatinine (Scr) concentration of 0.90 mg/dl, has an eGFR, according to 
the CKiDScr equation of 83 ml/min per 1.73 m2, while the CKD-EPI-equation yields an eGFR of 
124 ml/min per 1.73 m2. This discontinuity or abrupt change in GFR of 50% is physiologically 
implausible and may cause confusion to the patient and the care givers. Therefore, the Full Age 
Spectrum (FAS) equation was developed to guarantee continuity and applicability for the full 
age spectrum.3 At the age transition of 18 years, the FAS-eGFR of the example patient is 107.3 
ml/min per 1.73 m2. Selistre et al.4 examined the applicability of the CKiDScr and CKD-EPI-
equation in over 10,000 subjects spanning the entire age range (3-90 years) and concluded that 
in young adults, aged 18 to 30 years, the CKD-EPI equation seriously overestimated mGFR, 
whereas the CKiDScr equation underestimated mGFR. Very recently, Webster-Clark et al.5 
presented a longitudinal cohort study of 242 patients with CKD aged 10 to 30 years as they 
transitioned from the pediatric to adult nephrology care. They found poor agreement between 
the CKiDScr and the CKD-EPI equations in patients before and during the transition period with 
CKD-EPI consistently yielding higher eGFRs, especially in male patients. In 2 studies by our 
research group, we confirmed the finding that CKD-EPI overestimates mGFR in young adults and 
kidney donors. 6-8 In a recent review,9 we stated that eGFR equations performed best in the type 
of population for whom they were originally designed for, with preference for FAS in healthy 
and mildly kidney-diseased children (mGFR ≥75 ml/min per 1.73 m2) and with preference for 
the CKiDScr equation in kidney-diseased children (with mGFR <75 ml/ min per 1.73 m2). The 
Lund-Malmö-Revised equation (LMR) has been originally designed for an adult population,8 but 
it has shown good performance in a pediatric population with normal GFR on average. 10-11 As 
CKiDScr and CKD-EPI have opposite biases in young adults (18-30 years), Ng et al.12 recently 
proposed to average both equations in young adults in order to reduce bias and increase 
precision. However, their study was based on a rather limited dataset of 187 young adults, aged 
between 18 and 26 years, with 279 person-visits. They also did not specify at which age to 
switch to the adult eGFR equation, causing a new age transition problem at older age (26 years). 
The current study evaluates the performance of various creatinine-based eGFR equations in 
adolescents during the pediatric-adult transition period, using measured GFR as the reference. 
Results  
CROSS-SECTIONAL ANALYSIS 
The patient characteristics in the 5 centers are summarized in Table 1. Figure 1a to e presents 
the mGFR or eGFR plotted against age for 5764 children, adolescents, and young adults. We 
calculated the median GFR quantile versus age for the 10- to 18-year age interval and for the 18- 
to 30-year age interval, separately. For mGFR, the left median quantile line corresponds to 92 
(95% confidence interval [CI]: 88.6-94.8) ml/ min per 1.73 m2 at 18 years, whereas the right 
median quantile line corresponds to 88 (95% CI: 85.5-90.3) ml/min per 1.73 m2 at 18 years (P > 
0.05). For the KDIGO strategy, the left median quantile line corresponds to 77 (95% CI: 75.3-
78.9) ml/min per 1.73 m2, demonstrating the underestimation by CKiDScr, and the right median 
quantile using CKD-EPI corresponds to 118 (95% CI: 115.1-120.1) ml/min per 1.73 m2, 
indicating a large change in eGFR at the transition age (P < 0.0001). Neither FAS-Age nor FAS-Ht 
show a sudden change in eGFR at the transition age.  
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For FAS-Age, at the age of 18 years, the left median quantile is 94 (95% CI: 92.2-96.6) ml/min 
per 1.73 m2, and the right median quantile is 96 (95% CI: 91.9-98.8) ml/min per 1.73 m2 (P > 
0.05). For FAS-Ht, at the age of 18 years, the left median quantile is 90 (95% CI: 88.0-92.8) 
m/min per 1.73 m2, and the right is 92 (95% CI: 90.2-94.6) ml/min per 1.73 m2 (P > 0.05). This 
also applies to LMR with a left median quantile of 85 (95% CI:83.0-88.0) ml/min per 1.73 m2 
versus a right median quantile of 90 (95% CI: 87.1-92.1) ml/min per 1.73 m2 (P > 0.05). 
The same analysis was performed using 2 methods of calculating the average of the CKiDScr 
equation and the CKD-EPI equation at age ≥18 years (Figure 2a and b). Calculating the 
arithmetic mean of both equations in the young adults as proposed by Ng et al.12 (Figure 2a) 
does lead to a lower right median quantile of 101 (95% CI: 98.0-103.2) ml/min per 1.73 m2 at 
the age transition of 18 years, but this is still significantly higher than the CKiDScr-based left 
median quantile of 77 (95% CI: 75.3-78.9) ml/min per 1.73 m2 (P < 0.0001). As the CKiDScr 
equation demonstrates a slight underestimation at the transition age and the CKD-EPI equation 
has a large overestimation, using the average of both equations may decrease but does not solve 
the bias problem. 
By contrast, the age-weighted mean (Figure 2b) almost abolishes most of the jump in eGFR at 
transition with a right median quantile of 84 (95% CI: 81.3-86.0) ml/min per 1.73 m2 (P = 
0.00013). 
Figure 3 shows the median quantile regression lines for bias plotted versus age. Whereas bias 
changes steadily for FAS-Age, FAS-Ht, and LMR there is a sudden change in bias (from -6 to 22) 
when switching from CKiDScr to CKD-EPI at the age of 18 years. Bias is 0 for LMR, +5 ml/min per 
1.73 m2 for FAS-Ht, +9 ml/min per 1.73 m2 for FAS-Age, -6 ml/min per 1.73 m2 for CKiDScr, +22 
ml/min per 1.73 m2 for CKD-EPI, +9 ml/min per 1.73 m2 for the mean of CKiDScr and CKD-EPI 
and -5 ml/min per 1.73 m2 for the age-weighted mean of CKiDScr and CKD-EPI. The performance 
of all equations and combinations in terms of bias, P10 and P30, overall and in subgroups 
defined by mGFR below and above 75 ml/min per 1.73 m2 is presented in Table 2. Above 75 ml/ 
min per 1.73 m2, LMR outperforms the other equations and combinations irrespective of age, 
whereas the CKiDScr and the age-weighted mean approach yielded the best results for mGFR <75 
ml/min per 1.73 m2. In the Supplementary Methods and Results, we present these results 
separately for 45 ≤ mGFR < 75 ml/min per 1.73 m2 (Supplementary Table S1A) and for mGFR 
<45 ml/min per 1.73 m2 (Supplementary Table S1B), confirming the preceding conclusion that 
CKiDScr and the age-weighted mean approach are the best for low GFR. In Table 3, we restricted 
the analysis to the transition age range between 16 and 20 years of age. These results were 
comparable with those of the entire group. 
LONGITUDINAL ANALYSIS 
We evaluated 136 subjects in a longitudinal setting (70 female and 66 male patients). Baseline 
age was 14.6 ± 2.2 years (range 8.2 to 17.9). These patients all have serial measurements going 
through the transition age of 18 years. Fifty-six, 32, 22, 13, and 13 patients had 2, 3, 4, 5, and 
more than 5 serial measurements, respectively, and were on average, 18.1, 17.2, 16.6, 17.0, 17.1, 
and 17.7 years old during the selected age range of 10 to 30 years. There were 450 serial 
measurements in total for these 136 participants, with overall mean age of 17.4 years. Average 
follow-up time for these 136 subjects during the restricted age range of 10 to 30 years was 5.8 
years. Among these 136 patients, there were 52 subjects who had 1 GFR measurement between 
16 and 18 years and another between 18 and 20 years. 
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Table 1. Patient and method characteristics per center 
 Amsterdam Leuven Lund Lyon Stockholm Örebro Overall 
Number 321 482 483 2919 1379 180 5764 












mGFR (ml/min  
per 1.73 m2) 
89 (13-152) 81 (15-167) 90 (6-224) 87 (4-212) 85 (8-176) 87 (14-151) 86 (4-224) 
Female (%) 36 43 36 46 40 44 43 
Method Inulin pc 51Cr-EDTA pc lohexol pc Inulin 
rc/iohexol pc 
lohexol pc lohexol pc — 
Cr, creatinine; EDTA, ethylenediamine tetraacetic acid; mGFR, measured glomerular filtration rate; pc, plasma 
clearance; rc, renal clearance. Values are mean (minimum-maximum) unless otherwise indicated. 
 
In Table 4, we present the mean slope of the regression lines, calculated per patient for mGFR, 
FAS-Age, FAS-Ht, LMR, the KDIGO strategy, the Ng et al.12 strategy, and the age-weighted strategy 
to evaluate the possible decreasing (slope <-1), increasing (slope >+l), or stable situation 
(slope between -1 and +1) of kidney function over the considered time period. We also 
calculated the slope of the bias (i.e., eGFR - mGFR), which should preferably be close to 0, and 
the average root-mean-square error for all patients with at least 3 serial measurements. We 
further calculated the percentage of agreement with mGFR in defining the kidney function status 
as decreasing, stable, or improving. Table 5 contains the same summary statistics but restricted 
to the 52 patients with 1 measurement in the 16-to- 18-year age period and 1 measurement in 
the 18-to-20-year age period. 
Figure 1. Measured GFR (mGFR) (a) or estimated GFR (eGFR)—(b) creatinine-based Chronic 
Kidney Disease in Children (CKiDScr) and Chronic Kidney Disease Epidemiology Collaboration 
(CKD-EPI), (c) Full Age Spectrum (FAS)-Age, (d) FAS-Height (FAS-Ht), (e) Lund-Malmö-Revised 
equation (LMR)—for 3946 children (age <18 years) and for 1818 young adults (18 ≤ age ≤ 30 
years). The solid lines are the median quantiles calculated on mGFR or eGFR versus age 
separately for both age groups. 
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Figure 4a and b shows spaghetti plots of all 136 (or 52) GFR age profiles and the overall 
regression line for mGFR, the KDIGO strategy, FAS-Ht, and LMR. While mGFR declines (slope of -
2.0 ml/min per 1.73 m2/year), the KDIGO strategy yields a significantly different (P < 0.0001) 
positive slope (slope of +2.9 ml/min per 1.73 m2/year), falsely suggesting improved kidney 
function when transitioning from pediatric to adult care in these patients. In Figure 4b, every 
subject had 1 measurement in the 16-to-18-year age range and 1 follow-up measurement in the 
18-to-20-year age range. We hypothesized that in this short time period of <4 years, the kidney 
function did not change much or would slightly decrease (as these adolescents all had kidney 
pathologies). This hypothesis was well verified with mGFR, FAS-Age, FAS-Ht, and LMR, whereas 
the KDIGO strategy and Ng et al.12 strategy falsely suggested an improvement in kidney function. 
Figure 2. eGFR—(a) creatinine-based Chronic Kidney Disease in Children (CKiDScr) + average 
(Avg) of CKiDScr and Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI), (b) CKiDScr + 
age-weighted average of CKiDScr and CKD-EPI—for 3946 children (age <18 years) and for 1818 
young adults (18 ≤ age ≤ 30 years). The solid lines are the median quantiles calculated on eGFR 
versus age separately for both age groups. 
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This study was set up to study the performance of different methods to estimate GFR from Scr at 
the pediatric-adult care transition age of 18 years. The recommended strategy by KDIGO is to 
switch from the pediatric CKiDScr equation1 to the adult CKD-EPI equation.2 We compared the 
KDIGO strategy to the strategy recently proposed by Ng et al.,12 and several equations (i.e., FAS-
Age, FAS-Ht, LMR), which have been designed to cover the whole age span and are therefore 
supposed to be continuous at the pediatric-adult transition age. Finally, a novel approach using 
an age-weighted mean combining CKiDScr and CKD-EPI equation in young adults was tested. 
Overall, the equations designed for all ages (FAS-Age, FAS-Ht, and LMR) do not show abrupt 
jumps at the pediatric-adult transition age range. 
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Figure 3. Regression quantile lines for median bias ( = estimated glomerular filtration rate [eGFR] 
- measured GFR [mGFR]) versus age for the different eGFR equations. Avg, average; CKD-EPI, 
Chronic Kidney Disease Epidemiology Collaboration; CKiDScr, creatinine-based Chronic Kidney 




In line with previous studies we found that the CKiDScr equation underestimates GFR and CKD-
EPI overestimates GFR at the transition age of 18 years.4,9 This led Ng et al.12 to average both 
equations for young adults. The data from our cross-sectional analysis demonstrate that this 
approach only reduces the jump in bias from 23.2 ml/min per 1.73 m2 to 10.3 ml/min per 1.73 
m2, which still remains significant and clinically important. Our multicenter study confirms the 
findings by Selistre et al.13 who challenged the Ng et al.12 strategy in an independent dataset of 
543 subjects, aged between 18 and 26 years (the same age range used by Ng et al.) and 
concluded that the proposed solution by Ng et al. still overestimated mGFR. However, our 
sample of young adults is of Caucasian origin with an average mGFR = 85.7 ml/min per 1.73 m2, 
whereas Ng et al.12 studied only 187 young adults (20% African Americans) with more severe 
kidney malfunction (mGFR = 49 ml/min per 1.73 m2). In the Ng et al.12 study renal clearance of 
iothalamate was used as the reference method versus plasma clearance of various exogenous 
markers (inulin, iohexol, 51Cr-ethylenedi-amine tetraacetic acid) in our study. This may (partly) 
explain the much higher overestimation of CKD-EPI in our study than was observed by Ng et al. 
in their study.12 
The inadequacy of the KDIGO strategy is confirmed in the analysis of the longitudinal data where 
this strategy suggests an improvement (positive slope) in kidney function after transitioning 
whereas mGFR decreases (negative slope). 
Our data clearly demonstrate that the CKD-EPI equation (recommended by KDIGO for the 18-to-
30-year age period) is the main culprit for the implausible changes at 18 years. It strongly 
overestimates GFR in young adults with a large positive bias of 21 ml/min per 1.73 m2 in the age 
range of 18 to 20 years, decreasing to 19 ml/min per 1.73 m2 in the 20-to-24-year age group and 
9.5 ml/min per 1.73 m2 in the 24-to-30-year age groups. This corresponds to a poor P30 
accuracy of 60%, increasing to 64% and 78%, respectively. By contrast, using the CKiDScr 
equation in young adults has significantly lower bias and higher accuracy. These results suggest 
that the CKD-EPI equation should not be used on its own in young adults, which is in line with 
the findings of Selistre et al.4 
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Table 2. Performance of eGFR equations and combinations 
 FAS-Age FAS-Ht LMR KDIGO strategy3 Ng et al.12 strategyb Alternative strategy"1 









































14-18 84.9 2331 9.8 33.0 73.9 6.3 35.8 77.0 1.9 41.7 84.9 -0.5 38.2 83.7 -0.5 38.2 83.7 -0.5 38.2 83.7 
18-24 87.1 1303 8.1 32.2 74.4 2.5 34.2 80.6 -1.8 39.1 86.0 18.7 (-6.3) 24.0 (30.2) 64.4 (82.7) 5.2 40.7 80.1 -3.9 34.8 84.7 
24-30 82.3 515 7.8 33.2 74.6 1.6 31.3 80.4 -1.2 39.0 86.8 9.5 (-6.4) 34.8 (30.3) 77.5 (84.9) 1.8 38.6 84.1 -0.3 38.0 85.8 
10-18 86.8 3946 9.1 34.3 76.5 5.7 37.2 79.8 4.1 39.3 82.3 2.7 38.4 82.9 2.7 38.4 82.9 2.7 38.4 82.9 
18-30 85.7 1818 8.0 32.5 74.5 2.2 33.3 80.5 -1.8 39.1 86.2 15.2 (-6.4) 27.1 (30.3) 68.1 (83.3) 4.2 40.1 81.2 -2.9 35.7 85.0 
10-30 86.5 5764 8.7 33.7 75.8 4.7 36.0 80.0 2.0 39.2 83.6 6.4 (-0.1) 34.9 (35.9) 78.2 (83.0) 3.3 39.0 82.4 0.9 37.6 83.6 
mGFR <75 m l/min per 1.73 m2                   
10-14 53.5 511 10.1 26.6 67.5 6.1 33.3 77.7 17.0 14.3 46.8 7.9 31.1 73.4 7.9 31.1 73.4 7.9 31.1 73.4 
14-18 53.4 795 11.7 23.8 61.1 7.2 31.7 68.6 8.2 30.4 69.7 6.1 37.4 77.5 6.1 37.4 77.5 6.1 37.4 77.5 
18-24 53.2 415 14.5 14.9 50.1 6.7 27.2 71.6 6.7 32.5 69.6 18.6(2.0) 14.2 (28.2) 45.1 (80.2) 9.4 28.2 61.2 3.3 33.0 77.8 
24-30 49.3 188 10.8 16.0 56.4 6.8 24.5 71.3 4.2 39.9 73.9 10.1 (0.3) 20.2 (37.8) 63.8(85.1) 5.4 36.7 73.4 4.0 39.4 76.1 
10-18 53.4 1306 11.1 24.9 63.6 6.8 32.3 72.1 11.8 24.1 60.7 5.5 34.9 75.9 5.5 34.9 75.9 5.5 34.9 75.9 
18-30 52.0 603 13.0 15.3 52.1 6.8 26.4 71.5 5.5 34.8 71.0 15.6(1.5) 16.1 (31.1) 50.9(81.8) 8.0 30.8 65.0 3.6 35.0 77.3 
10-30 53.0 1909 11.7 21.8 60.0 6.8 30.4 71.9 9.8 27.5 64.0 7.8 (4.4) 29.0 (33.7) 68.0 (77.7) 6.3 33.6 72.4 5.0 34.9 76.3 
mGFR ≥75 ml/min per 1.73 m2 
10-14 106.4 1104 7.1 40.6 86.0 3.5 42.0 86.7 2.2 45.9 93.3 5.8 42.4 85.7 5.8 42.4 85.7 5.8 42.4 85.7 
14-18 101.1 1536 7.7 37.8 80.5 5.4 37.9 81.4 -2.8 47.5 92.8 -3.5 38.6 86.8 -3.5 38.6 86.8 -3.5 38.6 86.8 
18-24 102.9 888 4.6 39.1 83.3 -1.0 37.4 84.8 -7.7 42.2 93.7 16.6 (-12.2) 28.6 (31.2) 73.4 (83.8) 2.7 46.5 89.0 -8.7 35.7 88.0 
24-30 101.2 327 3.1 43.1 85.0 -3.8 35.2 85.6 -8.3 38.5 94.2 8.3 (-14.9) 43.1 (26.0) 85.3 (84.7) -2.9 39.8 90.2 -5.3 37.3 91.4 
10-18 103.3 2640 7.5 39.0 82.8 4.7 39.6 83.6 -0.8 46.8 93.0 0.3 40.2 86.4 0.3 40.2 86.4 0.3 40.2 86.4 
18-30 102.5 1215 4.2 40.2 83.8 -1.7 36.8 85.0 -8.0 41.2 93.8 15.1 (-13.2) 32.5 (29.8) 76.6 (84.0) 0.7 44.7 89.3 -8.0 36.1 88.9 
10-30 103.1 3855 6.3 39.4 83.1 2.9 38.7 84.0 -2.9 45.1 93.3 4.5 (-3.5) 37.8 (36.9) 83.3 (85.6) 0.3 41.6 87.3 -2.5 38.9 87.2 
CKiDScr, creatinine-based Chronic Kidney Disease in Children; eGFR, estimated glomerular filtration rate; FAS, Full Age Spectrum; FAS-Ht, FAS-Height; KDIGO, Kidney Disease Improving Global 
Outcomes; LMR, Lund-Ma I mo-Revised equation; mGFR, measured GFR. 
aThe combination of CKiD-Scr (when age < 18 years) and CKD-EPI (when age ≥ 18 years). 
bCombination of CKiD-Scr (when age < 18 years) and the average of CKiD-Scr and VKD-EPI (when age ≥18 years). 
cCombination of CKiD-Scr (when age < 18 years) and the weighed average of CKiD-Scr and CKD-EPI (when age ≥18 years). 
The statistics for the CKiDScr equation at age >18 years are given in parentheses. 
 
Table 3. Performance of eGFR equations at the transition ages of 16 to 20 years 
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Bias P10 P30 Bias P10 P30 Bias P10 P30 Bias P10 P30 Bias P10 P30 Bias P10 P30 
All 
16-18 
85.0 1272 10.4 33.0 73.7 5.5 36.2 78.0 0.1 42.8 88.0 -2.7 37.0 85.5 -2.7 37.0 85.5 -2.7 37.0 85.5 
18-20 88.5 650 11.0 32.2 70.8 3.4 36.0 79.7 -0.8 41.5 87.1 20.5 (-5.3) 19.2 (32.0) 60.0 (83.4) 7.6 38.0 78.6 -4.5 33.1 84.0 
Change   0.6   -2.1   -0.9   23.2 (-2.6)   10.3   -1.8   
mGFR <75 ml/min per 1.73 m2 
16-18 54.3 426 12.4 23.5 60.6 7.1 31.2 70.9 6.9 35.7 76.1 2.0 39.2 80.8 2.0 39.2 80.8 2.0 39.2 80.8 
18-20 54.5 196 14.9 15.3 47.4 8.5 26.5 72.4 6.9 32.1 72.4 20.3 (2.7) 11.7 (28.6) 41.3 (79.1) 10.4 21.4 59.2 3.1 29.6 77.6 
Change   2.5   1.4   0.0   18.3 (0.7)   8.4   1.1   
mGFR ≥75 ml/min per 1.73 m2 
16-18 100.5 846 8.8 37.8 80.3 4.3 38.7 81.6 -4.0 46.5 94.0 -6.6 35.9 87.9 -6.6 35.9 87.9 -6.6 35.9 87.9 
18-20 103.2 454 4.5 37.9 81.1 1.1 40.1 82.8 -6.2 45.6 93.4 20.5 (-10.1) 22.5 (33.5) 68.1 (85.2) 5.0 45.2 87.0 -9.0 34.6 86.8 
Change   -4.3   -3.2   -2.2   27.1 (-3.5)   11.6   -2.4   
CKiDScr, creatinine-based Chronic Kidney Disease in Children; eGFR, estimated glomerular filtration rate; FAS, Full Age Spectrum; FAS-Ht, FAS-Height; KDIGO, Kidney Disease Improving Global 
Outcomes; LMR, Lund-Ma I mo-Revised equation; mGFR, measured GFR. The statistics for the CKiDScr equation when age ≥18 years are given in parentheses. 
 
Based on the observation that the performance of the CKiDScr equation decreases with age in young adults while the opposite is true for CKD-EPI, we 
propose a novel approach using a gradual and linear transition from the CKiDScr equation to the CKD-EPI equation over an age period of 20 years by 
applying appropriate age-weighting of both equations. As it is known that the GFR decline in healthy subjects starts around the age of 40 years,6 the 
weighting factor was designed to give full weight to the CKiDScr equation at the age of 18 years and full weight to the CKD-EPI equation at the age of 
38 years. The rationale for the choice for 38 years in the weighting factor (38 — Age)/20 is explained in the Supplementary Methods and Results and 
Supplementary Figure S1.
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This weighted approach showed less bias and improved accuracy in our dataset compared with 
the method proposed by Ng et al.12 and performed at least as well as FAS-Ht in both mGFR 
subgroups. As the newly proposed equation was designed on theoretical grounds and not 
developed in our dataset, the current study may be considered as a first (semi) validation of this 
alternative combination of the CKiDScr and CKD-EPI equation in young adults. 
When comparing performance of the different approaches it becomes clear that the situation is 
quite different in mGFR subgroups. 
When mGFR is normal (i.e., ≥75 ml/min per 1.73 m2), all proposed equations, except the KDIGO 
strategy, have a bias < 10 ml/min per 1.73 m2, a bias change of <5 ml/min per 1.73 m2 and 
acceptable to excellent P30 accuracies between 80% and 95%. At normal GFR in the 18-to-30-
year age group, the CKD-EPI equation shows a large positive bias of 15 ml/min per 1.73 m2, 
whereas the CKiDScr equation has a large negative bias (underestimation by 13 ml/min per 1.73 
m2). This explains the low bias of 0.7 ml/min per 1.73 m2 and good accuracy of 89% of the Ng et 
al.12 strategy, although this strategy still shows a bias change of 12 ml/min per 1.73 m2 at the age 
transition. The best performing equation for mGFR ≥75 ml/min per 1.73 m2 is the LMR equation 
(with P30 = 94%), still this method has a stronger bias of -8.0 ml/ min per 1.73 m2 above the 
age of 18 years, which is also noted for the age-weighted mean. 
When mGFR is below 75 ml/min per 1.73 m2, bias change is still <3 ml/min per 1.73 m2 with 
FAS-Age, FAS-Ht, and LMR, and the weighted mean, but problematic for the KDIGO strategy (18 
ml/min per 1.73 m2) and the Ng et al.12 strategy (8.4 ml/min per 1.73 m2). Interestingly, when 
applied to the complete 10-to-30-year age range, the CKiDScr equation shows the best results of 
all equations in patients with diminished kidney function (P30 = 77.7%, bias of 4.4 ml/min per 
1.73 m2), demonstrating the applicability of CKiDScr even in the 18-to-30-year age range for 
kidney-diseased young adults. FAS-Age, LMR, and the recommended KDIGO approach should not 
be used here. The weighted mean method (P30 = 76%, bias = 5.0 ml/min per 1.73 m2) and the 
FAS-Ht equation (P30 = 72%, bias = 6.8 ml/min per 1.73 m2) are the second-best equations for 
children and young adults with reduced kidney function both in terms of accuracy and bias at 
the transition age of 18 years. Summarizing these data, considering the performance of the 
different equations and strategies, both above and below 75 ml/min per 1.73 m2, FAS-Ht and the 
weighted mean strategy have the most consistent performance, smallest bias overall, and the 
best P10 and P30 values, which makes them most suitable in situations when no prior 
information on the expected range of GFR is available in a given patient. 
Table 4. Summary statistics for 136 patients with serial data through the transition age 




Slope -2.0 [-2.8;-1.1] -0.1 [-1.5;1.4] -0.8 [-2.0;0.5] -0.9 [-1.6;-0.2] 2.9 [1.5;4.2] 0.6 [-0.6;1.8] -1.3 [-2.5;-
0.1] 
Slope bias  1.9 [0.5;3.3] 1.2 [0.0;24] 1.1 [0.2;1.9] 4.8 [3.6;6.0] 2.5 [1.5;3.6] 0.7 [-
0.5;1.8] 
RMSE of biasa  10.6 [8.8;12.4] 9.5 [7.9;11.1] 9.3 [7.9;10.7] 13.7 [11.7;15.7] 11.1 [9.5;12.7] 9.8 
[8.2;11.5] 
D/S/I kidney function 
patients (n) 
83/30/23 53/35/48 61/40/35 72/37/27 30/24/82 48/31/57 69/34/33 
Agreement (%)b  47.1 51.5 53.7 38.2 50.0 56.6 
D/S/l, decreasing, stable, improving; eGFR, estimated glomerular filtration rate; FAS, Full Age Spectrum; FAS-Ht, FAS-Height; 
KDIGO, Kidney Disease Improving Global Outcomes; LMR, Lund-Malmo-Revised equation; mGFR, measured GFR; RMSE, root-
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mean-square error. Bracketed values are the 95% confidence intervals. 
aRMSE of bias is calculated on 84 (of 136) subjects who had at least 3 data points. bPercentage of agreement represents the 
agreement between mGFR and eGFR in defining the status of kidney function over time (decreasing, stable, increasing). 
 
However, both methods require height to estimate GFR, which is not always available in the 
clinical laboratory, but the LMR and FAS-Age equation do not and eGFR can thus be reported 
automatically by the clinical laboratory, along with Scr. Whereas LMR performs well in adults,8 it 
is less suited for younger children and prepubertal children with diminished mGFR in the 
present study9,14. 
Our findings from the cross-sectional study are confirmed in the longitudinal analysis on 136 
subjects where an implausible jump is seen following the KDIGO strategy, but not in mGFR, the 
FAS equations, LMR, or the weighted approach. The average slope of mGFR of -2.0 ml/min per 
1.73 m2/year was significantly different from 0, indicating loss of kidney function over time in 
this cohort. The average slopes calculated for FAS-Age, FAS-Ht, LMR, and the weighted mean 
strategy were all negative and were not significantly different from the mGFR slope, whereas 
both the KDIGO strategy and the Ng et al.12 strategy showed positive slopes that were 
significantly different from the mGFR slope. This is even more obvious when the 52 patients 
with 1 measurement in the 16-to- 18-year time period and with 1 measurement in the 18-to-20-
year time period are considered. Although the Ng et al.12 strategy reduced the average slope 
from 15.1 ml/min per 1.73 m2/year to 7.0 ml/ min per 1.73 m2/year it was still strongly positive 
whereas the slope of mGFR and the other equations was not significantly different from 0. This is 
also reflected in the agreement between the courses of eGFR and mGFR where the KDIGO 
approach classified only 38% of patients correctly, whereas this was up to 60% for the other 
methods. The Ng et al.12 approach was clearly superior to KDIGO but less accurate than the 
weighted mean, LMR, and FAS-Ht. 
The strengths of this study are its large sample size and the availability of both cross-sectional 
and longitudinal data, passing the transition age at 18 years. Furthermore, Scr was measured 
with isotope dilution mass spectrometry-equivalent assays and GFR was directly measured with 
methods that have been shown to be sufficiently accurate.15 The data are coming from multiple 
centers, using different GFR measurement methods, representative for the method variability 
across Europe. 
The limitations of this study are that the participants are all Caucasian, leaving some uncertainty 
about the applicability of the FAS and LMR in the mixed ethnic population of the USA. The age-
weighted mean also warrants further validation in adults 31 to 38 years old, as this age span was 
part of the weighting scheme but was not included in the present dataset. mGFR using 
iothalamate was not available as this exogenous marker is not frequently used in Europe. We 
also did not evaluate the performance of other pediatric equations, such as the Schwartz-Lyon 
equation,16 which has been shown to perform better in a European pediatric population, 
especially in adolescents, but does not—based on unpublished results— solve the age-transition 
problem, as it underestimates GFR even more than the CKiDScr equation does above the age of 18 
years, especially in female patients. 
 
Table 5. Summary statistics for the 2-point serial data of 52 patients 
 mGFR FAS-Age FAS-Ht LMR KDIGO strategy Ng 
et al.12 strategy 
Alternative 
strategy 
Slope -2.2 [-5.30.9] 0.8 [-2.8;4.4] -0.4 [-3.7;2.9] -0.3 [-2.5;1.8] 15.1 [11.4;18.8] 7.0 [4.0;10.0] -0.4 [-3.4;2.6] 
Slope bias  3.0 [-0.3;6.4] 1.8 [-1.2;4.9] 1.9 [-07;4.5] 17.3 [13.0;21.7] 9.2 [5.9;12.6] 1.8 [-1.1;4.7] 
D/S/l kidney function 28/8/16 22/2/28 22/7/23 22/7/23 4/1/47 10/4/38 24/6/22 
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Agreement (%)a  57.7 59.6 59.6 34.6 46.2 61.5 
D/S/l, decreasing, stable, improving; eGFR, estimated glomerular filtration rate; FAS, Full Age Spectrum; FAS-Ht, FAS-Height; 
KDIGO, Kidney Disease Improving Global Outcomes; LMR, Lund-Malmö-Revised equation; mGFR, measured GFR. Bracketed 
values show 1 measurement within the 16-to-18-year age group and 1 within the 18-to-20-year age group. aPercentage of 
agreement represents the agreement between mGFR and eGFR in defining the status of kidney function over time 
(decreasing, stable, increasing). 
 
Figure 4. GFR age profiles for (a) 136 and (b) 52 subjects transitioning from pediatric to adult 
care: (upper left) measured GFR (mGFR), (upper right) Kidney Disease Improving Global 
Outcomes (KDIGO)-recommended equations, (bottom left) Full Age Spectrum-Height (FAS-Ht), 
and (bottom right) Lund-Malmö-Revised equation (LMR). 
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In conclusion, the KDIGO strategy to switch from the CKiDScr equation to the CKD-EPI equation at the transition age of 18 years causes implausible 
changes in eGFR and should be abandoned. The recently proposed Ng et al.12 strategy using the average of CKiDScr and CKD-EPI in young adults 
reduces this sudden change but does not solve the problem, especially in children with reduced GFR. This strategy also does not recommend at what 
age to switch to adult equations. The FAS-Ht equation is continuous throughout the age transition and also the weighted-mean approach does not 
show unexpected changes in eGFR estimates. Both have good accuracy and bias, making them a perfect alternative to the KDIGO strategy. LMR is the 
optimal method in adolescents with normal kidney function and CKiDScr is in patients with reduced kidney function, but this requires prior 
knowledge of the kidney status (normal or reduced). 
 
Table 6. eGFR equations 
Name eGFR equation 
CKiDScr1 0.413 x Ht/Scr 
CKD-EPI2 141 x (Scr/0.90)-1.209 x 0.993Age for male patients, if Scr/0.90 ≥ 1 
141 x (Scr/0.90)-0∙411 x 0.993Age for male patients, if Scr/0.90 < 1 
144 x (Scr/0.70)-1.209 x 0.993Age for female patients, if Scr/0.70 ≥ 1 
144 x (Scr/0.70)-0.329 x 0.993Age for female patients, if Scr/0.70 < 1 
FAS-Age3,17,19 107.3/[Scr/Q] where 
Q = 0.23 + 0.034 x age - 0.0018 x age2 + 0.00017 x age3 - 0.0000051 x age4, for girls <18 years 
Q = 0.21 + 0.057 x age - 0.0075 xage2 + 0.00064 xage3 - 0.000016 x age4, for boys <18 years 
Q = 0.70 for female patients when age ≥18 years; Q = 0.90 for male patients when age ≥18 years 
FAS-Ht19 107.3/[Scr/Q] where 
Q = 3.94 - 13.4 x Ht + 17.6 x Ht2 - 9.84 xHt3 + 2.04 x Ht4 (with Ht in m) 
LMR8 Exp[X - 0.0158 x age + 0.438 x ln(age)] where 
X = 2.5 + 0.0121 x (150 - Scr x 88.4) for female patients with Scr < 150/88.4 
X = 2.5 - 0.926 x In(Scr x 88.4/150) for female patients with Scr ≥ 150/88.4 
X = 2.56 + 0.00968 x (180 - Scr x 88.4) for male patients with Scr < 180/88.4 
X= 2.56 - 0.926 x In(Scr x 88.4/180) for male patients with Scr ≥ 180/88.4 
CKD-EPI, Chronic Kidney Disease Epidemiology Collaboration; CKiDScr, creatinine-based Chronic Kidney Disease in Children; eGFR, estimated glomerular filtration rate; FAS, Full Age Spectrum; 
FAS-Ht, FAS-Height; KDIGO, Kidney Disease Improving Global Outcomes; LMR, Lund-Malmö-Revised equation; Scr, serum creatinine.
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Recently, a new European working group European Kidney Function Consortium was initiated 
aiming at optimizing estimating and measuring GFR, standardization and harmonization, and 
denning fixed or age-dependent GFR thresholds. The European Kidney Function Consortium 
took the initiative to collect data on subjects undergoing mGFR, including Scr, serum cystatin C, 
age, sex, height, weight, and diagnosis. For the purpose of this study, we selected a subset from 
our large database, namely subjects between 10 and 30 years of age in order to focus on the age-
transition problem. This age-transition dataset contains 5 different cohorts of cross-sectional 
data from the Netherlands (Amsterdam, n — 321), Belgium (Leuven, n — 482), France (Lyon, n 
— 2919), and Sweden (Lund, Örebro and Stockholm, n — 2042), representing data from 
Southern, Central, and Northern Europe. Part of the data has been used and described in 
previous studies,16-24 while part of the data from Stockholm has not been published before. The 
present analysis includes 3946 measurements in children, aged between 10 and 18 years and 
1818 measurements in young adults, aged between 18 and 30 years. These data are used in the 
cross-sectional analysis. 
Another dataset from Lyon contained 136 subjects (non-transplanted patients) with serial data 
passing through the transition age of 18 years (i.e., at least 1 measurement of GFR before and at 
least 1 after the age of 18). These 136 subjects were studied in the longitudinal data analysis. 
All subjects were referred for direct GFR measurement because of suspected or manifest kidney 
disease, during the period between 2004 and 2016. All procedures involving subjects and data 
were in agreement with the ethical principles for medical research on human subjects 
established in the World Medical Association Declaration of Helsinki. Anonymization and 
pooling of the data with the intention to study the performance of eGFR equations was reviewed 
and approved by the Regional Ethical Board in Lund, Sweden. 
Scr was measured with an enzymatic assay (Roche [Basel, Switzerland] in Lyon, Leuven, and 
Stockholm; Abbott [Lake Bluff, IL] in Amsterdam and Lund), traceable to the isotope dilution 
mass spectrometry gold standard method. mGFR was obtained by different methods: inulin 
renal clearance in Lyon for part of the subjects, and plasma clearance in all other cases, using 
inulin in Amsterdam, 51Cr-ethylenediamine tetraacetic acid in Leuven, and iohexol in the other 
centers. The slope-intercept method with Bröchner-Mortensen correction, using 3 to 4 time 
points, was used for plasma clearance, except in Lund, where Jacobsson's iterative one-sample 
method25 is used when the subject weighs more than 40 kg, otherwise 2 samples were used. 
The eGFR equations considered in the current analysis are presented in Table 6. 
We analyzed the KDIGO strategy, which is the standard combination of CKiDScr (for ages <18 
years) with CKD-EPI (for ages ≥18 years); the Ng et al12 strategy, that is, CKiDScr for ages <18 
years and the average of CKiDScr and CKD-EPI for ages ≥18 years; and a new age-dependent 
alternative strategy combining CKiDScr for ages <18 years and the age-dependent weighted 
average of CKiDScr and CKD-EPI for ages ≥18 years. The weighing was as follows: eGFR — α × 
CKiDScr +(1-α)x CKD-EPI, with α = (38 - age)/20. This weighing factor is 1 (equal to CKiDScr) 
when age =18 years and becomes 0 (equal to CKD-EPI) when age — 38 years. Beyond 38 years, 
the CKD-EPI could further be applied. Besides, the FAS-Ht equation was validated as its 
performance has only been studied in children and adolescents, but not in young adults yet. 
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We presented the data in figures with median quantile regression lines, calculated for both 
mGFR versus age, and eGFR versus age, separately for the age ranges 10 to 18 years and 18 to 30 
years. The median quantile regression curve for bias (i.e., eGFR - mGFR) was plotted versus age, 
using a modification of a recently suggested approach.26 We used fractional polynomials for the 
quantile regression (proc quantreg in SAS [SAS Institute Inc., Cary, NC]) (linear and quadratic) 
and calculated the predicted median value with 95% CIs at the age of 18 years. These 95% CIs 
allowed us to estimate the modeling error at the "18-year end" of the quantile lines. Distinct 
95% CIs indicate a significant difference not related to quantile modeling error. We calculated 
bias and accuracy P10, P30 (i.e., percentage of estimates within ±10% or ±30% of mGFR) in the 
cross-sectional analysis, and the root-mean-square error for the different eGFR equations in the 
longitudinal analysis. The root-mean-square error (as a measure of accuracy for each equation) 
was calculated for each subject individually using all serial (n > 2) mGFR measurements of a 
given subject. Slopes of regression lines were compared between mGFR and eGFR, using a paired 
t-test. All calculations were done in SAS 9.4. 
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SUPPLEMENTARY MATERIAL 
Supplementary Methods and Results.  
Contains the rationale for the choice of the age threshold of 38 years in the weighting factor and 
the performance statistics (bias, P10, P30) for the low glomerular filtration rate (GFR) region 
(45 ≤ measured GFR [mGFR] < 75 ml/min per 1.73 m2 and mGFR < 45 ml/min per 1.73 m2). 
Figure S1. Bias (= estimated glomerular filtration rate [eGFR] - measured GFR [mGFR]) against 
age for different strategies, calculated in the total dataset. Each data point is the average bias of 
the corresponding 2-year age range; for example, at 19 years, the average bias of the 18-to-20-
year age range is shown. All presented strategies use the creatinine-based Chronic Kidney 
Disease in Children (CKiDScr) equation for ages <18 years and thus start from the common bias 
of -2.7 ml/min per 1.73 m2. 
Table S1A. Performance of estimated glomerular filtration rate (eGFR) equations and 
combinations. The statistics for the creatinine-based Chronic Kidney Disease in Children 
(CKiDScr) equation at age >18 years is given between brackets. 
Table S1B. Performance of estimated glomerular filtration rate (eGFR) equations and 
combinations. The statistics for the creatinine-based Chronic Kidney Disease in Children 
(CKiDScr) equation at age >18 years is given between brackets. Supplementary material is linked 
to the online version of the paper at www.kidney-international.org. 
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